Multi-state cannabis operator, Jushi Holdings Inc. (CSE: JUSH) (OTCQX: JUSHF) debuted its newly formulated vegan and gluten-free Tasteology Fruit Chews in Massachusetts, and expects to roll out the new product line in Virginia, Ohio and Nevada in Q1 2023.
Clinical stage psychedelics company atai Life Sciences (NASDAQ: ATAI) and its majority-owned subsidiary Perception Neuroscience completed patient enrollment for their Phase 2a clinical trial assessing the safety and efficacy of a single intravenous infusion (IV) dose of proprietary R-ketamine PCN-101 for patients
Canadian cannabis giant Canopy Growth Corporation (NASDAQ: CGC) (TSX:WEED) announced its intention to consolidate in the US via a new holding company dubbed Canopy
Cann American Corp. (OTCPK:CNNA), has entered into a binding letter of intent.
Under the terms of the agreement Cann American will acquire 80 million common shares of Mark2media Group, constituting 80% majority ownership in Mark2, in exchange of 1.5 million series B preferred shares of Cann American.
Entourage Health Corp. (TSX-V:ENTG) (OTCQX: ETRGF) (FSE:4WE), expanded its brand portfolio, releasing its most extensive suite of new products into the Canadian market to date.
Turning Point Brands, Inc. (NYSE: TPB), Q3 2022 net sales decreased 1.9% to $107.8 million compared to 109.9 million in Q3 2021.
Q3 2022 Financial Highlights